Covance, Drug Development Business of Labcorp has launched a new dedicated offering for Biotech, medical device and diagnostic companies following its purchase of Chiltern in 2017 .

https://www.outsourcing-pharma.com/Article/2018/01/10/Covance-New-offering-applies-Chiltern-developed-engagement-models